Press coverage about Fisher & Paykel Healthcare (OTCMKTS:FSPKF) has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than 6,000 news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Fisher & Paykel Healthcare earned a media sentiment score of -1.33 on their scale. InfoTrie also assigned media headlines about the company an news buzz score of 0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news stories that may have impacted Fisher & Paykel Healthcare’s ranking:
- Oxygen Therapy Equipment Market Global Analysis by Size, Share, Trend, Growth, Trend, Future Predications, Valuable Industry by 2023 (benzinga.com)
- Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Earns Daily Media Sentiment Score of -1.33 (americanbankingnews.com)
- Medical Sleep Apnea Devices Market is expected to peak demand with Featuring Expert Panel (marketwatch.com)
- Pressure Mode Ventilators Market A comprehensive study by 2025 (marketwatch.com)
- Oxygen Therapy Equipment Market Clinical Reviews and Survey Reports 2019 (marketwatch.com)
OTCMKTS FSPKF opened at $11.95 on Friday. Fisher & Paykel Healthcare has a twelve month low of $8.30 and a twelve month high of $11.95. The business’s fifty day moving average is $11.06 and its 200 day moving average is $10.51.
Fisher & Paykel Healthcare Company Profile
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA).
See Also: What is the Bid-Ask Spread?
Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.